James M. DeTore
Geen lopende functies
Profiel
James M.
DeTore worked as a Principal at Data General Corp.
and Genzyme Corp.
He was the Vice President-Finance & Administration at Ironwood Pharmaceuticals, Inc. from 2012 to 2014 and the Controller at Microbia, Inc. from 2003 to 2006.
He also served as the Chief Financial Officer & Treasurer at bluebird bio, Inc. from 2014 to 2016 and at Proteostasis Therapeutics, Inc. from 2016 to 2017.
DeTore earned an undergraduate degree and an MBA from Northeastern University.
Eerdere bekende functies van James M. DeTore
| Bedrijven | Functie | Einde |
|---|---|---|
| PROTEOSTASIS THERAPEUTICS, INC. | Director of Finance/CFO | 10-02-2017 |
| BLUEBIRD BIO, INC. | Director of Finance/CFO | 01-03-2016 |
| IRONWOOD PHARMACEUTICALS, INC. | Director of Finance/CFO | 17-06-2011 |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Comptroller/Controller/Auditor | 01-01-2006 |
Data General Corp.
 Data General Corp. Computer PeripheralsElectronic Technology Data General Corp. designs and makes open computer systems including servers and mass storage products. The company was founded in 1968 and is headquartered in Westborough, MA | Corporate Officer/Principal | - |
Opleiding van James M. DeTore
| Northeastern University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Data General Corp.
Data General Corp. Computer PeripheralsElectronic Technology Data General Corp. designs and makes open computer systems including servers and mass storage products. The company was founded in 1968 and is headquartered in Westborough, MA | Electronic Technology |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Microbia, Inc.
Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Health Technology |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
